• BioLife Solutions held a special shareholder meeting on Oct. 5, 2026 to vote on a Repligen merger deal.
• Stockholders adopted the merger agreement, clearing the required vote to proceed with the transaction.
• An advisory resolution on merger-related compensation was approved.
• A resolution to allow adjournment of the meeting, if needed to seek more votes, was also approved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioLife Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-415012), on October 06, 2026, and is solely responsible for the information contained therein.